Skip to main content
. 2021 May 13;12:649026. doi: 10.3389/fmicb.2021.649026

Figure 1.

Figure 1

Galleria mellonella survival curves following infection with Candida spp. (A) Candida albicans R14; (B) Candida parapsilosis N101; (C) Candida tropicalis 00279; (D) Candida glabrata 05448; (E) Candida auris AR385; Untreated Group, wild type uninfected larvae; Saline Group, wild type larvae injected with saline; Conidial Group, larvae infected with Candida without any treatment; MIN Group, Candida-infected larvae treated with MIN only; fluconazole (FLU) Group, Candida-infected larvae treated with FLU only; itraconazole (ITC) Group, Candida-infected larvae treated with ITC only; voriconazole (VOR) Group, Candida-infected larvae treated with VOR only; posaconazole (POS) Group, Candida-infected larvae treated with POS only; MIN+FLU Group, Candida-infected larvae treated with MIN combined with FLU; MIN+ITC Group, Candida-infected larvae treated with MIN combined with ITC; MIN+VOR Group, Candida-infected larvae treated with MIN combined with VOR; MIN+POS Group, Candida-infected larvae treated with MIN combined with POS. ∗p < 0.05.